Mastelli S.r.l. initiates study on PN+HA for skin hydration improvement
A post-market clinical investigation is underway to evaluate the efficacy and safety of PN+HA for skin hydration.
Asset / Drug
Drug and asset intelligence for Mastelli with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.